Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
Scope of the Report:The classification of Heart Defect Closure Devices includes ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. And the proportion of Amplatzer PFO Occluder in 2019 is about 33%, and the proportion is in decreasing trend from 2013 to 2018. LAA Closure Devices with the growth rate about 18%, in 2019 the market share is nearly 22%.
Heart Defect Closure Devices is widely used in hospitals and clinics. The most proportion of Heart Defect Closure Devices is used in Hospital, and the proportion in 2019 is 61%. Europe is the largest consumption place, with a consumption market share nearly 30% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 27%.
Market competition is not intense. Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates and Starway are the leaders of the industry, with high-end customers.
The worldwide market for Heart Defect Closure Devices is expected to grow at a CAGR of roughly 8.6% over the next five years, will reach 1009.6 million US$ in 2026, from 667.9 million US$ in 2020, according to a new study.
This report focuses on the Heart Defect Closure Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Market Segment by Applications, can be divided into Hospitals
Clinics
The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Heart Defect Closure Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heart Defect Closure Devices, with price, sales, revenue and global market share of Heart Defect Closure Devices in 2018 and 2019.
Chapter 3, the Heart Defect Closure Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heart Defect Closure Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Heart Defect Closure Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2026.
Chapter 13, 14 and 15, to describe Heart Defect Closure Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
